The existing Abrysvo label is for adults age 60+. (Abrysvo is also approved as a maternal RSV vaccine to protect infants during their first RSV season.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.